Physician profile
Gaurav Shah
NPI 1508128380
$11,677.21
in general payments reported to CMS, 2019-2025
8 companies · $11K in 2025
The $11K reported for 2025 was more than what 99% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $21.28 · 2021: $84.85 · 2022: $18.97 · 2024: $180 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,997.24 |
| Food and Beverage | $253.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Envista Holdings Corporation | $10,997.24 | 2025 | Education |
| Zimmer Biomet Holdings, INC. | $257.72 | 2019-2024 | |
| Dentsply Sirona INC | $253.20 | 2019-2025 | Astra Tech Implant System |
| Straumann USA LLC | $78.03 | 2019-2020 | |
| Align Technology, INC. | $35.74 | 2024 | Invisalign |
| Geistlich Pharma, North America, INC. | $20.39 | 2019 | |
| Biohorizons Implant Systems INC. | $18.97 | 2022 | |
| Henry Schein, INC. | $15.92 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaurav Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.